GILD logo

Gilead Sciences (GILD) Cash from operations

annual CFO:

$10.83B+$2.82B(+35.25%)
December 31, 2024

Summary

  • As of today (May 23, 2025), GILD annual cash flow from operations is $10.83 billion, with the most recent change of +$2.82 billion (+35.25%) on December 31, 2024.
  • During the last 3 years, GILD annual CFO has fallen by -$556.00 million (-4.88%).
  • GILD annual CFO is now -49.04% below its all-time high of $21.25 billion, reached on December 31, 2015.

Performance

GILD Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDcash flow metrics

quarterly CFO:

$1.76B-$1.22B(-40.94%)
March 1, 2025

Summary

  • As of today (May 23, 2025), GILD quarterly cash flow from operations is $1.76 billion, with the most recent change of -$1.22 billion (-40.94%) on March 1, 2025.
  • Over the past year, GILD quarterly CFO has dropped by -$462.00 million (-20.82%).
  • GILD quarterly CFO is now -69.68% below its all-time high of $5.79 billion, reached on December 31, 2015.

Performance

GILD quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDcash flow metrics

TTM CFO:

$10.37B-$462.00M(-4.27%)
March 1, 2025

Summary

  • As of today (May 23, 2025), GILD TTM cash flow from operations is $10.37 billion, with the most recent change of -$462.00 million (-4.27%) on March 1, 2025.
  • Over the past year, GILD TTM CFO has increased by +$1.89 billion (+22.23%).
  • GILD TTM CFO is now -51.22% below its all-time high of $21.25 billion, reached on December 31, 2015.

Performance

GILD TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

GILD Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+35.3%-20.8%+22.2%
3 y3 years-4.9%-4.5%-2.3%
5 y5 years+18.4%+22.4%+15.1%

GILD Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-4.9%+35.3%-59.2%+32.6%-4.3%+38.8%
5 y5-year-4.9%+35.3%-59.2%+32.6%-8.9%+38.8%
alltimeall time-49.0%+8627.4%-69.7%+1342.6%-51.2%+8263.5%

GILD Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.76B(-40.9%)
$10.37B(-4.3%)
Dec 2024
$10.83B(+35.2%)
$2.98B(-31.0%)
$10.83B(+8.0%)
Sep 2024
-
$4.31B(+225.2%)
$10.02B(+34.2%)
Jun 2024
-
$1.32B(-40.3%)
$7.47B(-11.9%)
Mar 2024
-
$2.22B(+2.3%)
$8.48B(+5.9%)
Dec 2023
$8.01B(-11.8%)
$2.17B(+23.6%)
$8.01B(-4.7%)
Sep 2023
-
$1.75B(-24.9%)
$8.40B(-11.6%)
Jun 2023
-
$2.34B(+34.1%)
$9.51B(+6.0%)
Mar 2023
-
$1.74B(-32.1%)
$8.98B(-1.1%)
Dec 2022
$9.07B(-20.3%)
$2.57B(-10.3%)
$9.07B(-6.6%)
Sep 2022
-
$2.86B(+58.9%)
$9.71B(-3.9%)
Jun 2022
-
$1.80B(-2.1%)
$10.10B(-4.8%)
Mar 2022
-
$1.84B(-42.6%)
$10.61B(-6.8%)
Dec 2021
$11.38B(+39.4%)
$3.21B(-1.5%)
$11.38B(+12.8%)
Sep 2021
-
$3.25B(+40.5%)
$10.10B(+11.0%)
Jun 2021
-
$2.32B(-11.3%)
$9.09B(-2.7%)
Mar 2021
-
$2.61B(+36.2%)
$9.34B(+14.4%)
Dec 2020
$8.17B(-10.7%)
$1.92B(-14.8%)
$8.17B(-7.5%)
Sep 2020
-
$2.25B(-12.3%)
$8.83B(-4.3%)
Jun 2020
-
$2.57B(+78.7%)
$9.23B(+2.5%)
Mar 2020
-
$1.44B(-44.3%)
$9.00B(-1.5%)
Dec 2019
$9.14B(+8.9%)
$2.58B(-2.5%)
$9.14B(+2.6%)
Sep 2019
-
$2.65B(+12.9%)
$8.91B(+5.1%)
Jun 2019
-
$2.34B(+48.5%)
$8.48B(+10.0%)
Mar 2019
-
$1.58B(-32.8%)
$7.71B(-8.3%)
Dec 2018
$8.40B(-29.4%)
$2.35B(+6.0%)
$8.40B(-4.6%)
Sep 2018
-
$2.21B(+40.6%)
$8.81B(-5.2%)
Jun 2018
-
$1.57B(-30.7%)
$9.29B(-17.4%)
Mar 2018
-
$2.27B(-17.5%)
$11.24B(-5.5%)
Dec 2017
$11.90B(-30.2%)
$2.75B(+2.2%)
$11.90B(-6.2%)
Sep 2017
-
$2.69B(-23.6%)
$12.68B(-11.8%)
Jun 2017
-
$3.53B(+20.5%)
$14.38B(-9.2%)
Mar 2017
-
$2.92B(-17.3%)
$15.84B(-7.1%)
Dec 2016
$17.05B(-19.8%)
$3.54B(-19.4%)
$17.05B(-11.7%)
Sep 2016
-
$4.39B(-11.9%)
$19.30B(+1.6%)
Jun 2016
-
$4.99B(+20.7%)
$19.01B(-3.4%)
Mar 2016
-
$4.13B(-28.7%)
$19.68B(-7.4%)
Dec 2015
$21.25B(+65.8%)
$5.79B(+41.5%)
$21.25B(+15.0%)
Sep 2015
-
$4.10B(-27.6%)
$18.48B(+0.3%)
Jun 2015
-
$5.66B(-0.8%)
$18.42B(+8.7%)
Mar 2015
-
$5.70B(+88.7%)
$16.95B(+32.2%)
Dec 2014
$12.82B(+312.8%)
$3.02B(-25.3%)
$12.82B(+21.8%)
Sep 2014
-
$4.04B(-3.4%)
$10.52B(+45.5%)
Jun 2014
-
$4.18B(+166.9%)
$7.23B(+80.8%)
Mar 2014
-
$1.57B(+115.7%)
$4.00B(+28.9%)
Dec 2013
$3.10B(-2.8%)
$726.80M(-3.5%)
$3.10B(+0.7%)
Sep 2013
-
$753.10M(-21.0%)
$3.08B(+0.3%)
Jun 2013
-
$953.00M(+41.8%)
$3.08B(-9.9%)
Mar 2013
-
$672.10M(-4.8%)
$3.41B(+6.9%)
Dec 2012
$3.19B(-12.2%)
$706.01M(-5.3%)
$3.19B(-7.8%)
Sep 2012
-
$745.37M(-42.2%)
$3.47B(-4.2%)
Jun 2012
-
$1.29B(+184.9%)
$3.62B(+10.6%)
Mar 2012
-
$452.97M(-53.7%)
$3.27B(-10.1%)
Dec 2011
$3.64B(+28.4%)
$978.11M(+9.0%)
$3.64B(+7.5%)
Sep 2011
-
$897.11M(-4.9%)
$3.39B(+4.9%)
Jun 2011
-
$943.25M(+15.0%)
$3.23B(+8.2%)
Mar 2011
-
$820.54M(+13.2%)
$2.98B(+5.3%)
Dec 2010
$2.83B(-8.0%)
$724.84M(-2.0%)
$2.83B(-7.5%)
Sep 2010
-
$739.42M(+5.8%)
$3.06B(-3.8%)
Jun 2010
-
$699.08M(+4.3%)
$3.19B(+2.4%)
Mar 2010
-
$670.57M(-29.8%)
$3.11B(+0.9%)
Dec 2009
$3.08B(+43.7%)
$955.28M(+11.0%)
$3.08B(+13.7%)
Sep 2009
-
$860.53M(+38.1%)
$2.71B(+14.8%)
Jun 2009
-
$622.92M(-2.9%)
$2.36B(+8.3%)
Mar 2009
-
$641.33M(+9.7%)
$2.18B(+1.7%)
Dec 2008
$2.14B
$584.75M(+14.2%)
$2.14B(+3.5%)
Sep 2008
-
$512.05M(+16.1%)
$2.07B(+14.4%)
DateAnnualQuarterlyTTM
Jun 2008
-
$441.07M(-27.2%)
$1.81B(-3.8%)
Mar 2008
-
$605.51M(+18.3%)
$1.88B(+6.5%)
Dec 2007
$1.77B(+44.9%)
$511.99M(+103.8%)
$1.77B(+1.9%)
Sep 2007
-
$251.20M(-50.9%)
$1.73B(+0.0%)
Jun 2007
-
$511.72M(+4.3%)
$1.73B(+16.5%)
Mar 2007
-
$490.49M(+2.3%)
$1.49B(+22.1%)
Dec 2006
$1.22B(+72.6%)
$479.51M(+91.2%)
$1.22B(+13.9%)
Sep 2006
-
$250.76M(-5.7%)
$1.07B(+57.9%)
Jun 2006
-
$265.90M(+19.8%)
$677.40M(-3.3%)
Mar 2006
-
$221.89M(-33.0%)
$700.31M(-0.8%)
Dec 2005
$705.64M(+38.9%)
$331.01M(-334.1%)
$705.64M(+42.5%)
Sep 2005
-
-$141.40M(-149.0%)
$495.26M(-38.3%)
Jun 2005
-
$288.81M(+27.1%)
$803.30M(+26.1%)
Mar 2005
-
$227.22M(+88.4%)
$636.98M(+25.4%)
Dec 2004
$507.96M(+116.5%)
$120.63M(-27.6%)
$507.96M(+4.3%)
Sep 2004
-
$166.64M(+36.0%)
$487.24M(+30.0%)
Jun 2004
-
$122.49M(+24.7%)
$374.92M(+20.2%)
Mar 2004
-
$98.21M(-1.7%)
$311.87M(+32.9%)
Dec 2003
$234.61M(+215.3%)
$99.91M(+84.0%)
$234.61M(+37.8%)
Sep 2003
-
$54.31M(-8.6%)
$170.24M(-3.7%)
Jun 2003
-
$59.44M(+183.8%)
$176.70M(+49.2%)
Mar 2003
-
$20.94M(-41.1%)
$118.47M(+59.2%)
Dec 2002
$74.41M(-158.6%)
$35.55M(-41.5%)
$74.41M(+1502.3%)
Sep 2002
-
$60.77M(+4922.0%)
$4.64M(-105.3%)
Jun 2002
-
$1.21M(-105.2%)
-$87.22M(-27.2%)
Mar 2002
-
-$23.11M(-32.4%)
-$119.85M(-5.6%)
Dec 2001
-$126.98M(+232.4%)
-$34.22M(+10.0%)
-$126.98M(+9.3%)
Sep 2001
-
-$31.10M(-1.0%)
-$116.17M(+22.5%)
Jun 2001
-
-$31.41M(+3.9%)
-$94.83M(+50.8%)
Mar 2001
-
-$30.25M(+29.2%)
-$62.89M(+64.6%)
Dec 2000
-$38.20M(-39.0%)
-$23.41M(+139.8%)
-$38.20M(+61.9%)
Sep 2000
-
-$9.76M(-1955.7%)
-$23.59M(-34.2%)
Jun 2000
-
$526.00K(-109.5%)
-$35.87M(-36.2%)
Mar 2000
-
-$5.56M(-36.8%)
-$56.25M(-10.2%)
Dec 1999
-$62.60M(+22.0%)
-$8.80M(-60.1%)
-$62.60M(-5.3%)
Sep 1999
-
-$22.04M(+11.0%)
-$66.10M(-6.3%)
Jun 1999
-
-$19.85M(+66.6%)
-$70.56M(+25.1%)
Mar 1999
-
-$11.91M(-3.1%)
-$56.41M(+10.0%)
Dec 1998
-$51.30M(-5.9%)
-$12.30M(-53.6%)
-$51.30M(-40.2%)
Sep 1998
-
-$26.50M(+364.9%)
-$85.80M(+24.9%)
Jun 1998
-
-$5.70M(-16.2%)
-$68.70M(+7.7%)
Mar 1998
-
-$6.80M(-85.5%)
-$63.80M(+17.1%)
Dec 1997
-$54.50M(+230.3%)
-$46.80M(+397.9%)
-$54.50M(+1334.2%)
Sep 1997
-
-$9.40M(+1075.0%)
-$3.80M(-167.9%)
Jun 1997
-
-$800.00K(-132.0%)
$5.60M(-186.2%)
Mar 1997
-
$2.50M(-35.9%)
-$6.50M(-60.6%)
Dec 1996
-$16.50M(-28.3%)
$3.90M(>+9900.0%)
-$16.50M(-19.1%)
Sep 1996
-
$0.00(-100.0%)
-$20.40M(-21.8%)
Jun 1996
-
-$12.90M(+72.0%)
-$26.10M(+22.5%)
Mar 1996
-
-$7.50M(+31.6%)
-$21.30M(-27.1%)
Dec 1995
-$23.00M(-16.1%)
-
-
Sep 1995
-
-$5.70M(-29.6%)
-$29.20M(+8.6%)
Jun 1995
-
-$8.10M(+8.0%)
-$26.90M(-1.8%)
Mar 1995
-
-$7.50M(-5.1%)
-$27.40M(+2.6%)
Mar 1995
-$27.40M(+22.3%)
-
-
Dec 1994
-
-$7.90M(+132.4%)
-$26.70M(+6.4%)
Sep 1994
-
-$3.40M(-60.5%)
-$25.10M(+0.8%)
Jun 1994
-
-$8.60M(+26.5%)
-$24.90M(+11.2%)
Mar 1994
-$22.40M(+151.7%)
-$6.80M(+7.9%)
-$22.40M(+10.9%)
Dec 1993
-
-$6.30M(+96.9%)
-$20.20M(+20.2%)
Sep 1993
-
-$3.20M(-47.5%)
-$16.80M(+30.2%)
Jun 1993
-
-$6.10M(+32.6%)
-$12.90M(+44.9%)
Mar 1993
-$8.90M(+140.5%)
-$4.60M(+58.6%)
-$8.90M(+107.0%)
Dec 1992
-
-$2.90M(-514.3%)
-$4.30M(+207.1%)
Sep 1992
-
$700.00K(-133.3%)
-$1.40M(-33.3%)
Jun 1992
-
-$2.10M
-$2.10M
Mar 1992
-$3.70M(+54.2%)
-
-
Mar 1991
-$2.40M
-
-

FAQ

  • What is Gilead Sciences annual cash flow from operations?
  • What is the all time high annual CFO for Gilead Sciences?
  • What is Gilead Sciences annual CFO year-on-year change?
  • What is Gilead Sciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Gilead Sciences?
  • What is Gilead Sciences quarterly CFO year-on-year change?
  • What is Gilead Sciences TTM cash flow from operations?
  • What is the all time high TTM CFO for Gilead Sciences?
  • What is Gilead Sciences TTM CFO year-on-year change?

What is Gilead Sciences annual cash flow from operations?

The current annual CFO of GILD is $10.83B

What is the all time high annual CFO for Gilead Sciences?

Gilead Sciences all-time high annual cash flow from operations is $21.25B

What is Gilead Sciences annual CFO year-on-year change?

Over the past year, GILD annual cash flow from operations has changed by +$2.82B (+35.25%)

What is Gilead Sciences quarterly cash flow from operations?

The current quarterly CFO of GILD is $1.76B

What is the all time high quarterly CFO for Gilead Sciences?

Gilead Sciences all-time high quarterly cash flow from operations is $5.79B

What is Gilead Sciences quarterly CFO year-on-year change?

Over the past year, GILD quarterly cash flow from operations has changed by -$462.00M (-20.82%)

What is Gilead Sciences TTM cash flow from operations?

The current TTM CFO of GILD is $10.37B

What is the all time high TTM CFO for Gilead Sciences?

Gilead Sciences all-time high TTM cash flow from operations is $21.25B

What is Gilead Sciences TTM CFO year-on-year change?

Over the past year, GILD TTM cash flow from operations has changed by +$1.89B (+22.23%)
On this page